Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, China
NCT Number: NCT03230331
This study aims to evaluate the long term effect of deep brain stimulation in the the subthalamic nucleus (STN) in patients with Parkinson's disease.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Observational
Shanghai, China
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: above 10 years post surgery
Time frame: above 10 years post surgery
Time frame: above 10 years post surgery
Time frame: above 10 years post surgery
Time frame: above 10 years post surgery
Time frame: above 10 years post surgery
Time frame: above 10 years post surgery
Time frame: above 10 years post surgery
Time frame: above 10 years post surgery
Time frame: above 10 years post surgery
Time frame: above 10 years post surgery
Time frame: above 10 years post surgery
Time frame: above 10 years post surgery
Time frame: above 10 years post surgery
Ruijin Hospital
Other
Long Term Study of Subthalamic Deep Brain Stimulation for Parkinson's Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06671938
Autonomic Nervous System Diseases, Basal Ganglia Diseases
Bydgoszcz, Poland
View Trial DetailsNCT04620551
Basal Ganglia Diseases, Brain Diseases
Omaha, Nebraska, United States
View Trial DetailsNCT03192046
Basal Ganglia Diseases, Brain Diseases
Dallas, Texas, United States
View Trial DetailsNCT01496599
Basal Ganglia Diseases, Brain Diseases
Bethesda, Maryland, United States
View Trial Details